coagulation

(redirected from Coagulation cascade)
Also found in: Dictionary, Medical, Legal, Encyclopedia, Wikipedia.
Related to Coagulation cascade: Coagulation factors
  • noun

Synonyms for coagulation

References in periodicals archive ?
The coagulation cascade sustains a prothrombotic state when not actively being modulated by the anticoagulant pathways as a result of activation of TF pathways.
Thrombocytopenia and heparin's effect on the coagulation cascade might have then allowed progression of hemorrhage and formation of the large lingual hematoma.
In higher organisms, the coagulation cascade is activated to stop the loss of blood after vascular injury by forming a fibrin clot.
Tissue factor's pivotal role as an initiator of the blood coagulation cascade has been well documented in the scientific literature.
14) Protein S and protein C are major inhibitors of the coagulation cascade and, when activated, act as anticoagulants.
Thus, the coagulation cascade and the fibrinolytic systems are functionally separate.
This means that the immune system and coagulation cascade are left practically unaffected by blood/membrane contact.
Platelet effects, rather than interference with the coagulation cascade, are responsible for gingos anticoagulant activity, said Dr.
Two of the new proteins thwart clotting by binding to and inactivating factor Xa; the third protein stymies factor VIIa and "inhibits the initiation of the entire coagulation cascade," says Vlasuk.
Researchers shared data from a pilot study of GMI-1070, now in Phase 2 clinical trials, via the oral presentation, which was entitled, "Pan-selectin Antagonist GMI-1070 Affects Biomarkers of Adhesion, Activation and the Coagulation Cascade in Sickle Cell Patients at Steady State.
This novel designed compound is being investigated for its ability to circumvent specific steps of the natural coagulation cascade with the goal of reducing the dosing frequency as compared to the currently available recombinant bypassing agent.
In the coagulation cascade, factors V and VIII are glycoprotein cofactors for the proteolytic activation of prothrombin (factor II) by factor X and of factor X by factor IX, respectively, and thus are essential for clot formation.
We have also pioneered a commercial test for the dilute prothrombin time test, or dPT test, which measures lupus anticoagulants from the external pathway of the coagulation cascade.
High levels of thrombin-antithrombin complexes and activation of the coagulation cascade lead to higher use and thus depletion of coagulation inhibitors.